Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 1
Submit an article Journal homepage
143
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era

Alice Laurengea Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-0058-3176View further author information
ORCID Icon,
Renata Ursub Service de Neurologie, AP-HP, Hôpital Saint Louis, Université de Paris, Paris, FranceView further author information
,
Emeline Tabouretc APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service de Neurooncologie, Aix-Marseille University, Marseille, FranceORCID Iconhttps://orcid.org/0000-0002-4031-2178View further author information
ORCID Icon,
Vincent Harlayc APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service de Neurooncologie, Aix-Marseille University, Marseille, FranceView further author information
,
Guido Ahled Service de Neurologie, Hôpitaux Civils de Colmar, Colmar, FranceORCID Iconhttps://orcid.org/0000-0002-0877-2289View further author information
ORCID Icon,
Sylvain Choquete Service d’Hématologie Clinique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-7791-0470View further author information
ORCID Icon,
Carole Soussainf Service d’Hématologie, Institut Curie, site de Saint-Cloud et INSERM U932 Institut Curie, PSL Research University, Paris;g LOC Network, Paris, FranceView further author information
,
Cécile Moluçon-Chabroth Service de Thérapie Cellulaire et Hématologie Clinique, CHU de Clermont-Ferrand – Hôpital d'Estaing, Clermont-Ferrand, FranceView further author information
,
Bertrand Mathoni Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-9182-5846View further author information
ORCID Icon,
Karima Mokhtarij Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Service de Neuropathologie Laboratoire Escourolle, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, FranceView further author information
,
Valérie Pourcherk INSERM 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Service de Maladies Infectieuses et Tropicales, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, FranceView further author information
,
Lucia Nichellil Service de Neuroradiologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Paris, FranceView further author information
,
Stéphane Marotm INSERM 1136, Institut Pierre Louis D’Epidémiologie Et de Santé Publique, Département de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-4438-5793View further author information
ORCID Icon,
Mehdi Touata Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, FranceView further author information
,
Khê Hoang-Xuana Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, France;g LOC Network, Paris, FranceView further author information
&
Caroline Houilliera Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière – Charles Foix, Sorbonne Université, Paris, France;g LOC Network, Paris, FranceCorrespondence[email protected]
View further author information
 show all
Pages 221-224 | Received 01 Jul 2022, Accepted 19 Sep 2022, Published online: 01 Nov 2022

References

  • Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
  • Xia Y, Jin R, Zhao J, et al. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e180.
  • He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645.
  • Martín-Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190(1):e16–e20.
  • Jain A, Nayak L, Kulkarni UP, et al. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India. Blood Cancer J. 2022;12(1):2.
  • Laurenge A, Ursu R, Houillier C, et al. SARS-CoV-2 infection in patients with primary Central nervous system lymphoma. J Neurol. 2021;268(9):3072–3080.
  • ECDC. Covid-19 situation-updates. [En ligne]. Disponible sur. https://www.ecdc.europa.eu/en/covid-19/situation-updates
  • Galmiche S, Luong Nguyen LB, Tartour E, et al. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect. 2022;28(2):163–177.
  • Takashita E, Kinoshita N, Yamayoshi S, et al. Efficacy of antibodies and antiviral drugs against covid-19 omicron variant. N Engl J Med. 2022;386(10):995–998.
  • Abrey LE, Batchelor TT, Ferreri AJM, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23(22):5034–5043.
  • Bromberg JEC, Issa S, Bakunina K, et al. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2019;20(2):216–228.
  • Cesaro S, Ljungman P, Mikulska M, juin ECIL 9, et al. « Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 european conference on infections in leukaemia (ECIL 9. Leukemia. 2022;36(6):1467–1480.
  • Tixagevimab and cilgavimab (evusheld) for pre-exposure prophylaxis of COVID-19. JAMA. 2022;327(4):384–385.
  • Fung M, Nambiar A, Pandey S, et al. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis. 2021;23(2):e13477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.